Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
CAS
1310726-60-3
Purity
95%
Upadacitinib is an oral selective inhibitor of tyrosine-protein kinase JAK1 and a disease-modifying antirheumatic drug. It is used in the treatment of rheumatoid arthritis to slow down disease progression.
Properties
Name
Upadacitinib
Smiles
CC[C@@H]1CN(C[C@@H]1C2=CN=C3C=NC=4NC=CC4N23)C(=O)NCC(F)(F)F
Targets
Please log in to see this information
ABT-494 | upadacitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$56
2 mg
$61
5 mg
$66
10 mg
$83
15 mg
$91
20 mg
$99
25 mg
$111
30 mg
$118
35 mg
$127
40 mg
$143
45 mg
$153
50 mg
$165
75 mg
$235
100 mg
Get a quoteQuantity
1
Total amount
$ 66
ABT-494 | upadacitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
Powered by Bioz